GlaxoSmithKline PLC (GSK) — Financial Flexibility Index
GlaxoSmithKline PLC (GSK) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of GBX3.10 Billion (operating CF GBX2.22 Billion minus capex GBX879.00 Million) represents 0% of total liabilities (GBX45.59 Billion). Check GlaxoSmithKline PLC PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GlaxoSmithKline PLC Financial Flexibility Index (1991–2024)
Historical Financial Flexibility Index trend for GlaxoSmithKline PLC across 35 annual periods. See GlaxoSmithKline PLC short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for GlaxoSmithKline PLC (1991–2024)
Year-by-year free cash flow to debt coverage for GlaxoSmithKline PLC. For the full company profile including market capitalisation, see GlaxoSmithKline PLC market capitalisation.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | GBX9.54 Billion | GBX6.55 Billion | GBX46.38 Billion | ▲ +4.3% |
| 2023 | 0.20x | GBX9.11 Billion | GBX6.77 Billion | GBX46.21 Billion | ▲ +2.2% |
| 2022 | 0.19x | GBX9.66 Billion | GBX7.40 Billion | GBX50.05 Billion | ▲ +2.4% |
| 2021 | 0.19x | GBX10.88 Billion | GBX7.95 Billion | GBX57.76 Billion | ▲ +5.2% |
| 2020 | 0.18x | GBX10.68 Billion | GBX8.44 Billion | GBX59.62 Billion | ▲ +7.9% |
| 2019 | 0.17x | GBX10.18 Billion | GBX8.02 Billion | GBX61.34 Billion | ▼ -11.6% |
| 2018 | 0.19x | GBX10.22 Billion | GBX8.42 Billion | GBX54.39 Billion | ▲ +8.9% |
| 2017 | 0.17x | GBX9.12 Billion | GBX6.92 Billion | GBX52.89 Billion | ▲ +5.5% |
| 2016 | 0.16x | GBX8.85 Billion | GBX6.50 Billion | GBX54.12 Billion | ▲ +63.0% |
| 2015 | 0.10x | GBX4.47 Billion | GBX2.57 Billion | GBX44.57 Billion | ▼ -48.3% |
| 2014 | 0.19x | GBX6.93 Billion | GBX5.18 Billion | GBX35.72 Billion | ▼ -25.5% |
| 2013 | 0.26x | GBX8.92 Billion | GBX7.22 Billion | GBX34.27 Billion | ▲ +53.4% |
| 2012 | 0.17x | GBX5.89 Billion | GBX4.38 Billion | GBX34.73 Billion | ▼ -27.8% |
| 2011 | 0.23x | GBX7.58 Billion | GBX6.25 Billion | GBX32.25 Billion | ▼ -10.0% |
| 2010 | 0.26x | GBX8.43 Billion | GBX6.80 Billion | GBX32.31 Billion | ▼ -13.7% |
| 2009 | 0.30x | GBX9.71 Billion | GBX7.84 Billion | GBX32.12 Billion | ▲ +0.2% |
| 2008 | 0.30x | GBX9.38 Billion | GBX7.31 Billion | GBX31.07 Billion | ▼ -19.8% |
| 2007 | 0.38x | GBX7.94 Billion | GBX5.79 Billion | GBX21.09 Billion | ▲ +7.9% |
| 2006 | 0.35x | GBX5.55 Billion | GBX3.96 Billion | GBX15.90 Billion | ▲ +1.2% |
| 2005 | 0.34x | GBX6.77 Billion | GBX5.59 Billion | GBX19.63 Billion | ▲ +16.8% |
| 2004 | 0.30x | GBX5.02 Billion | GBX4.77 Billion | GBX17.01 Billion | ▼ -23.1% |
| 2003 | 0.38x | GBX5.91 Billion | GBX4.85 Billion | GBX15.40 Billion | ▲ +33.9% |
| 2002 | 0.29x | GBX4.29 Billion | GBX3.06 Billion | GBX14.94 Billion | ▼ -32.0% |
| 2001 | 0.42x | GBX5.73 Billion | GBX4.61 Billion | GBX13.57 Billion | ▲ +80.5% |
| 2000 | 0.23x | GBX2.96 Billion | GBX1.85 Billion | GBX12.63 Billion | ▲ +52.8% |
| 1999 | 0.15x | GBX1.11 Billion | GBX510.00 Million | GBX7.23 Billion | ▲ +13.7% |
| 1998 | 0.13x | GBX885.00 Million | GBX410.00 Million | GBX6.58 Billion | ▼ -14.5% |
| 1997 | 0.16x | GBX1.03 Billion | GBX615.00 Million | GBX6.55 Billion | ▼ -11.3% |
| 1996 | 0.18x | GBX1.25 Billion | GBX849.00 Million | GBX7.05 Billion | ▼ -23.8% |
| 1995 | 0.23x | GBX1.94 Billion | GBX1.25 Billion | GBX8.32 Billion | ▼ -40.3% |
| 1995 | 0.39x | GBX2.93 Billion | GBX2.45 Billion | GBX7.53 Billion | ▼ -34.4% |
| 1994 | 0.59x | GBX1.63 Billion | GBX1.05 Billion | GBX2.74 Billion | ▲ +8.5% |
| 1993 | 0.55x | GBX1.53 Billion | GBX927.00 Million | GBX2.80 Billion | ▼ -10.5% |
| 1992 | 0.61x | GBX1.25 Billion | GBX657.00 Million | GBX2.04 Billion | ▲ +23.5% |
| 1991 | 0.50x | GBX1.22 Billion | GBX615.00 Million | GBX2.46 Billion | — |